Dehydroabietic acid chloride was prepared via the reaction of dehydroabietic acid and thionylchloride, dehydroabietic acid acylthiosemicarbazide was synthesized by thiosemicarbazone and dehydroabietic acid chloride, followed by the reaction of dehydroabietic acid acylthiosemicarbazide, aromatic aldehydes with ethyl acetate to obtain ten dehydroabietic acid amide derived 3, 4-dihydropyrimidinones: 4-phenyl-6-methyl-1-dehydroabietic acid amide-3, 4-dihydropyrimidine-2-thione (3a), 4-(4-methoxyphenyl)-6-methyl-1-dehydroabietic acid amide-3, 4-di-hydropyrimidine-2-thione (3b), 4-(2-methoxyphenyl)-6-methyl-1-dehydroabietic acid amide-3, 4-dihydropyrimi-dine-2-thione (3c), 4-(4-methylphenyl)-6-methyl-1-dehydroabietic acid amide-3, 4-dihydropyrimidine-2-thione (3d), 4-(4-bromophenyl)-6-methyl-1-dehydroabietic acid amide-3, 4-dihydropyrimidine-2-thione (3e), 4-(4-p-tri-fluoromethylphenyl)-6-methyl-1-dehydroabietic acid amide-3, 4-dihydropyrimidine-2-thione (3f). 4-(4-chlorophen-yl)-6-methyl-1-dehydroabietic acid amide-3, 4-dihydropyrimidine-2-thione (3g), 4-(2, 6-dichlorophenyl)- 6-methyl-1-dehydroabietic acid amide-3, 4-dihydropyrimidine-2-thione (3h), 4-(2-nitrophenyl)-6-methyl-1-dehydroabietic acid amide-3, 4-dihydropyrimidine-2-thione (3i), 4-(3-nitrophenyl)-6-methyl-1-dehydroabietic acid amide-3, 4-di-hydropyrimidine-2-thione (3j).The target compounds were characterized by FT-IR, MS, 1H NMR and 13C NMR. The cytotoxicity of these 3, 4-dihydropyrimidinone derivatives (compounds 3a-3j) were tested with monkey embryonic kidney cells (MA-104 cells). The antiviral activities against the Herpes simplex virus type Ⅰ (HSV-1) of these derivatives were further evaluated with methyl thiazolyl tetrazolium(MTT) method. The results indicated that the cytotoxicity of these derivatives kept in a low level, compounds 3a, 3b, 3d, 3e, 3h, 3i and 3j showed lower cytotoxicity than the drug ribavirin; compound 3j performed better inhibitory activity of HSV-1(50% inhibitory concentration(IC50) 0.465 g/L, selective index(SI)12.18) which was similar to ribavirin (IC50=0.156 g/L, SI=12.6), and the other compounds showed weak inhibitory activity of HSV-1.